Patents Assigned to Boehringer Mannhein Pharmaceutical Corporation
  • Novel oral dosage form for carvedilol
    Publication number: 20040220250
    Abstract: The present invention discloses a matrix formulation containing carvedilol.
    Type: Application
    Filed: January 16, 2003
    Publication date: November 4, 2004
    Applicants: Boehringer Mannhein Pharmaceutical Corporation, SmithKline Beckman Corporation, Limited Partnership No. 1
    Inventor: Choon K. Oh